Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$401M |
| 2 |
NVIDIA
NVDA
|
+$333M |
| 3 |
Costco
COST
|
+$236M |
| 4 |
Amazon
AMZN
|
+$215M |
| 5 |
Johnson & Johnson
JNJ
|
+$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$322M |
| 2 |
Super Micro Computer
SMCI
|
+$284M |
| 3 |
JPMorgan Chase
JPM
|
+$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
+$160M |
| 5 |
Intel
INTC
|
+$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FGNX
3051
Fundamental Global
FGNX
$9.23M
| $466K | ﹤0.01% |
17,760
-3,673
| -17% | -$96.4K |
|
|
ACB
3052
Aurora Cannabis
ACB
$272M
| $465K | ﹤0.01% |
79,121
-7,167
| -8% | -$42.1K |
|
3053
ReposiTrak
TRAK
$318M
| $463K | ﹤0.01% |
25,063
| – | – |
|
3054
Biohaven
BHVN
$1.53B
| $458K | ﹤0.01% |
9,157
-3
| -0% | -$150 |
|
3055
Mexco Energy
MXC
$17M
| $454K | ﹤0.01% |
37,366
-1,563
| -4% | -$19K |
|
3056
BV Financial
BVFL
$166M
| $453K | ﹤0.01% |
29,507
+4
| +0% | +$61 |
|
3057
NovoCure
NVCR
$1.41B
| $450K | ﹤0.01% |
28,769
-895
| -3% | -$14K |
|
3058
Root
ROOT
$1.56B
| $444K | ﹤0.01% |
11,764
-6,225
| -35% | -$235K |
|
3059
Rentokil
RTO
$13B
| $440K | ﹤0.01% |
17,651
+1,721
| +11% | +$42.9K |
|
3060
CPI Aerostructures
CVU
$32.8M
| $436K | ﹤0.01% |
126,776
-12,562
| -9% | -$43.2K |
|
3061
Ultragenyx Pharmaceutical
RARE
$3.04B
| $430K | ﹤0.01% |
7,748
-2,227
| -22% | -$124K |
|
3062
Sangamo Therapeutics
SGMO
$158M
| $428K | ﹤0.01% |
493,686
-24,517
| -5% | -$21.2K |
|
3063
Flotek Industries
FTK
$336M
| $424K | ﹤0.01% |
85,174
+48,547
| +133% | +$242K |
|
3064
Red Robin
RRGB
$110M
| $424K | ﹤0.01% |
96,063
+2,327
| +2% | +$10.3K |
|
3065
Lake Shore Bancorp
LSBK
$102M
| $423K | ﹤0.01% |
31,372
+4
| +0% | +$54 |
|
|
LBPH
3066
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $421K | ﹤0.01% |
12,626
-1,115
| -8% | -$37.2K |
|
3067
Coda Octopus Group
CODA
$90M
| $419K | ﹤0.01% |
57,819
+4
| +0% | +$29 |
|
3068
Treace Medical Concepts
TMCI
$449M
| $416K | ﹤0.01% |
71,743
| – | – |
|
3069
TELUS International
TIXT
$1.25B
| $413K | ﹤0.01% |
105,682
-25,980
| -20% | -$102K |
|
|
QVCGA
3070
QVC Group, Inc. Series A Common Stock
QVCGA
$79M
| $410K | ﹤0.01% |
13,446
-20
| -0.1% | -$610 |
|
3071
J.W. Mays
MAYS
| $396K | ﹤0.01% |
8,620
+1
| +0% | +$46 |
|
|
TOUR
3072
Tuniu
TOUR
$105M
| $394K | ﹤0.01% |
279,361
-35,414
| -11% | -$49.9K |
|
3073
Grupo SIMEC
SIM
$3.84B
| $393K | ﹤0.01% |
14,216
+158
| +1% | +$4.37K |
|
3074
Loar Holdings
LOAR
$7.33B
| $392K | ﹤0.01% |
+5,260
| New | +$392K |
|
3075
PepGen
PEPG
$48.9M
| $387K | ﹤0.01% |
+45,232
| New | +$387K |
|